Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Год журнала:
2024,
Номер
unknown, С. 1 - 32
Опубликована: Авг. 28, 2024
The
immune
system
plays
a
major
role
leading
to
extraordinary
immunotherapeutic
interventions.
Immune
checkpoint
blockade
has
emerged
as
revolutionary
development
in
cancer
therapeutics.
Adoptive
cell
therapy
(ACT)
come
out
promising
avenue,
involving
the
infusion
of
tumor-infiltrating
lymphocytes
(TIL)
or
genetically
engineered
T
cells
showing
innovative
receptors
(TCR)
chimeric
antigen
(CAR).
These
interventions
encourage
utilize
capacity
target
tumor
successfully.
Supportive
outcomes
have
been
recorded
across
various
types,
resulting
advancement
global
clinical
trials
refine
and
improvise
ACT
protocols.
Significantly
favorable
results
seen
hematological
malignancies
well
impressive
case
against
solid
tumors
become
an
important
milestone
for
researchers.
This
chapter
discusses
different
types
advancements
ACT,
describes
associated
toxicities,
predicts
its
future
potential
therapeutics
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 2, 2025
Suppression
of
chimeric
antigen
receptor-modified
T
(CAR-T)
cells
by
the
immunosuppressive
tumor
microenvironment
remains
a
major
barrier
to
their
efficacy
against
solid
tumors.
To
address
this,
we
develop
an
anti-PD-L1-expressing
nanovesicle
loaded
with
STING
agonist
cGAMP
(aPD-L1
NVs@cGAMP)
remodel
and
thereby
enhance
CAR-T
cell
activity.
Following
pulmonary
delivery,
nanovesicles
rapidly
accumulate
in
lung
selectively
deliver
agonists
PD-L1-overexpressing
via
PD-1/PD-L1
interaction.
This
targeted
delivery
effectively
avoids
systemic
inflammation
poor
cellular
uptake
that
plague
free
agonists.
Internalized
trigger
signaling
induce
interferon
responses,
which
diminish
populations
such
as
myeloid-derived
suppressor
promote
infiltration.
Importantly,
anti-PD-L1
single
chain
variable
fragment
on
surface
blocks
PD-L1
upregulation
induced
prevents
exhaustion.
In
both
orthotopic
cancer
metastasis
model,
combined
therapy
aPD-L1
NVs@cGAMP
potently
inhibits
growth
recurrence.
Therefore,
is
expected
serve
effective
enhancer
improve
The
hindered
Here
authors
report
design
characterization
inhalable
cGAMP,
showing
enhanced
activity
models.
ABSTRACT
Cell
transplantation
therapy
in
the
central
nervous
system
is
hindered
by
limited
survival
and
integration
of
grafted
cells.
Biomaterials
have
emerged
as
an
attractive
solution
to
this
problem
providing
a
protective
microenvironment
deliver
cells
injured
tissues.
The
design
biomaterials
compatible
with
tissues
promote
tissue
repair
functional
recovery
focus
neural
engineering.
A
wealth
research
has
explored
different
materials
architectures
combination
bioactive
cues
glial
cell
growth
maturation.
After
brief
presentation
biomaterial
strategies
sources,
we
review
vivo
evidences
about
efficacy
stem
cotransplantation
(i)
enhancing
trophic
effects,
(ii)
increasing
integration,
(iii)
achieving
preclinical
models
stroke,
traumatic
brain
injury,
Parkinson's
disease,
spinal
cord
injury.
Furthermore,
comprehensive
perspective
was
offered
regarding
specific
implementation
tactics,
obstacles,
development
orientations
employing
critical
support
transplantation.
Biomaterials,
Год журнала:
2025,
Номер
317, С. 123085 - 123085
Опубликована: Янв. 5, 2025
T
cell
therapy
for
solid
tumors
faces
significant
challenges
due
to
the
immune
off-target
attack
caused
by
loss
of
tumor
surface
antigens
and
inactivation
in
acidic
microenvironment
(TME).
Herein,
we
developed
a
bifunctional
immunomodulator
(MO@NAL)
loading
ovalbumin
(OVA;
model
antigen)
mRNA
(mOVA)
onto
lysozyme-coated
layered
double
hydroxide
nano-aluminum
adjuvant
(NA).
The
NA's
inherent
alkalinity
effectively
neutralizes
excess
acid
within
TME
suppresses
regulatory
cells,
creating
favorable
enhance
cytotoxic
infiltration
activation
tumors.
Particularly,
once
internalization
MO@NAL
efficiently
tags
with
OVA
through
carried
mOVA,
providing
targets
recruiting
directing
antigen-specific
cells
destroy
cells.
In
mice
pre-vaccinated
vaccine,
intratumoral
administration
rapidly
awakens
OVA-specific
memory,
inhibiting
progression
colon
melanoma
at
both
early
advanced
stages.
non-pre-vaccinated
mice,
combining
therapeutic
vaccine
or
adoptive
transfusion
similarly
achieves
robust
suppression.
These
findings
thus
underscore
potential
as
an
effective
safe
enhancing
responses
timely
intervention
progression.
Materials Today Bio,
Год журнала:
2025,
Номер
31, С. 101476 - 101476
Опубликована: Янв. 9, 2025
Stem
cell-based
therapy
has
emerged
as
a
promising
approach
for
heart
repair,
potentially
regenerating
damaged
tissue
and
improving
outcomes
patients
with
disease.
However,
the
efficacy
of
stem
therapies
remains
limited
by
several
challenges,
including
poor
cell
survival,
low
retention
rates,
integration,
functional
outcomes.
This
article
reviews
current
enhancement
strategies
to
optimize
mesenchymal
cardiac
repair.
Key
approaches
include
optimizing
delivery
methods,
enhancing
engraftment,
promoting
functions
through
genetic
molecular
modifications,
paracrine
effects
cells,
leveraging
biomaterials
engineering
techniques.
By
focusing
on
these
techniques,
paper
highlights
innovative
that
can
transform
into
more
viable
effective
treatment
option
The
ongoing
research
technological
advancements
continue
push
boundaries,
hoping
make
mainstream
Materials Today Bio,
Год журнала:
2025,
Номер
31, С. 101517 - 101517
Опубликована: Янв. 22, 2025
Chimeric
antigen
receptor
T-cell
(CAR-T)
therapy,
which
benefits
from
the
perfect
combination
of
gene
editing
techniques
and
antibody
engineering,
has
shown
outstanding
clinical
efficacy
in
hematological
malignancies.
Solid
tumors
present
next
challenge
due
to
their
extremely
complicated
microenvironment
structural
characteristics.
Targeting
efficiency
persistence
are
currently
bottleneck
issues
treatment
CAR-T.
Beyond
drugs
cytokines,
biomaterials
can
modulate
immune
response,
assisting
adoptive
CAR-T
cells
exerting
function.
In
this
study,
a
supramolecular
peptide
hydrogel
epitope
vaccine
was
designed
serve
as
both
preparation
medium
reservoir
for
cells.
The
self-assembling
formed
nanofiber
scaffold
through
non-covalent
interactions
amphiphilic
amino
acids
ion
stabilizers.
Firstly,
complementary
conjugated
epitopes
target
sites
were
derived
different
extracellular
domains
HER2
protein,
improved
tumor
spreading
targeting
efficiency.
promoted
cell
proliferation,
cytotoxic
activity,
lymphocyte
subpopulation
transformation.
Furthermore,
encapsulated
(SPEV-CAR-T)
induced
endogenous
humoral
cellular
responses
sustained
release
cells,
demonstrating
superior
anti-tumor
effects
an
vivo
mouse
model.
Most
importantly,
SPEV-CAR-T
central
memory
systemic
tissues,
addressing
poor
single
therapy.
integration
complementation
active
passive
all-in-one
system
facilitated
sequential
succession
exogenous
responses,
promoting
persistent
specific
attack.
showed
therapeutic
solid
tumors.
Polymers,
Год журнала:
2024,
Номер
16(19), С. 2765 - 2765
Опубликована: Сен. 30, 2024
Smart
materials
for
drug
delivery
are
designed
to
offer
a
precise
and
controlled
release
of
therapeutic
agents.
By
responding
specific
physiological
stimuli,
such
as
changes
in
temperature
pH,
these
improve
treatment
efficacy
minimize
side
effects,
paving
the
way
personalized
solutions.
In
this
study,
we
present
fabrication
dual-responsive
alginate/poly(N-isopropylacrylamide)
(PNIPAM)
microspheres,
having
ability
respond
both
pH
variations
embedding
lipophilic
bioactive
compound
Ozoile.
Ozoile®
Stable
Ozonides
is
obtained
from
extra
virgin
olive
oil
acts
an
inducer,
interacting
with
major
biological
pathways
by
means
modulating
systemic
redox
balance.
The
microspheres
prepared
electrospray
technique
without
use
organic
solvents.
PNIPAM
synthesized
radical
polymerization
using
APS/TEMED
initiators.
further
optimized
chitosan
coating
enhance
their
stability
modulate
degradation
kinetics
gel
matrix.
A
comprehensive
morphological
analysis,
Fourier
transform
infrared
(FTIR)
spectroscopy,
assays
conducted
confirm
structural
pH-responsive
behavior
hydrogel
microspheres.
study
volume
phase
transition
(VPTT)
differential
scanning
calorimetry
(DSC)
used
assess
microsphere
thermal
response.
This
research
introduces
promising
methodology
development
targeted
systems,
which
particularly
useful
context
oxidative
stress
modulation
inflammation
management.
Advanced Functional Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 9, 2024
Abstract
Cancer
immunotherapy
has
revolutionized
cancer
treatment
by
leveraging
the
immune
system
to
target
and
eliminate
tumor
cells.
Implantable
biomaterials,
such
as
hydrogels,
sponges,
scaffolds,
implantable
microdevice
platforms,
macrobeads,
offer
localized
sustained
release
of
immunomodulatory
agents,
improving
delivery
treatments
checkpoint
inhibitors,
vaccines,
adoptive
cell
therapies
like
CAR‐T
This
review
examines
emerging
role
these
biomaterials
in
modulating
microenvironment,
enhancing
recruitment,
reducing
systemic
side
effects,
positioning
them
significant
tools
for
treating
solid
tumors.
Recent
advances
material
engineering
are
also
discussed,
including
integration
bioactive
molecules
real‐time
therapeutic
adjustments
based
on
patient‐specific
responses,
which
new
potential
personalized
treatments.
However,
challenges
biocompatibility,
high
production
costs,
variability
patient
response,
necessity
surgical
manipulations
remain
key
obstacles.
Nonetheless,
ongoing
research
technological
advancements
steadily
addressing
issues,
paving
way
more
effective
accessible
immunotherapies.
Overall,
this
highlights
promise
overcoming
current
limitations
expanding
scope
effective,
targeted
Journal of Materials Chemistry B,
Год журнала:
2024,
Номер
13(1), С. 117 - 136
Опубликована: Ноя. 6, 2024
This
article
reviews
the
application
of
biomaterials
in
combination
with
immunotherapy
to
enhance
localized
treatment
tumors,
along
current
challenges
and
future
development
directions
this
field.